Holen Sie sich die Stockscreener-App
14.01
0.36%
0.05
Handel nachbörslich:
14.01
Schlusskurs vom Vortag:
$13.96
Offen:
$14.44
24-Stunden-Volumen:
4.39M
Relative Volume:
13.41
Marktkapitalisierung:
$404.68M
Einnahmen:
$31.38M
Nettoeinkommen (Verlust:
$-6.69M
KGV:
-53.88
EPS:
-0.26
Netto-Cashflow:
$-1.84M
1W Leistung:
+3.24%
1M Leistung:
-30.09%
6M Leistung:
+7.36%
1J Leistung:
+321.99%
1-Tages-Spanne:
$13.52
$14.61
1-Wochen-Bereich:
$13.09
$14.61
52-Wochen-Spanne:
$3.22
$21.48
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Firmenname
Eton Pharmaceuticals Inc
Sektor
Telefon
(847) 787-7361
Adresse
21925 W. FIELD PARKWAY, DEER PARK, IL
Vergleichen Sie ETON mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
14.01 | 404.68M | 31.38M | -6.69M | -1.84M | -0.26 |
|
RGC
Regencell Bioscience Holdings Ltd
|
17.40 | 303.95B | 0 | -5.87M | -767.30K | -0.45 |
|
ZTS
Zoetis Inc
|
156.17 | 74.39B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.38 | 48.97B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 47.39B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.76 | 20.17B | 16.54B | -1.64B | 749.00M | -1.45 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-23 | Bestätigt | H.C. Wainwright | Buy |
| 2025-01-10 | Eingeleitet | B. Riley Securities | Buy |
| 2025-01-06 | Bestätigt | H.C. Wainwright | Buy |
| 2024-09-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2024-05-06 | Eingeleitet | Craig Hallum | Buy |
| 2021-10-14 | Fortgesetzt | B. Riley Securities | Buy |
| 2021-01-04 | Bestätigt | H.C. Wainwright | Buy |
| 2019-09-20 | Eingeleitet | B. Riley FBR | Buy |
| 2019-06-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Eton Pharmaceuticals Inc Aktie (ETON) Neueste Nachrichten
Opaleye Management Inc. Increases Stake in Eton Pharmaceuticals Inc. - GuruFocus
Insiders Back These 3 High Growth Companies - Yahoo Finance
Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) 25% Cheaper Price Remains In Tune With Revenues - simplywall.st
Bank of America Corp DE Boosts Stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Insider Sell: David Krempa Sells 34,000 Shares of Eton Pharmaceu - GuruFocus
Insider Sell: David Krempa Sells 34,000 Shares of Eton Pharmaceuticals Inc (ETON) - GuruFocus
Eton Pharma wins FDA nod for oral hydrocortisone solution - MSN
Eton Pharmaceuticals, Inc. (ETON) Launches Game-Changer for Adrenal Insufficiency - MSN
Major Shareholder Increases Stake in Eton Pharmaceuticals! - TipRanks
Eton Pharmaceuticals Holds Annual Stockholders Meeting - TipRanks
Eton Pharmaceuticals (ETON) Stock Price, News & Analysis - MarketBeat
Trend Tracker for (ETON) - news.stocktradersdaily.com
B. Riley Forecasts Higher Earnings for Eton Pharmaceuticals - Defense World
B. Riley Boosts Earnings Estimates for Eton Pharmaceuticals - Defense World
Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside - Seeking Alpha
Insider Sell: Sean Brynjelsen Sells 210,000 Shares of Eton Pharm - GuruFocus
Two Sigma Advisers LP Invests $662,000 in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Two Sigma Investments LP Invests $1.50 Million in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals (ETON) Upgraded to Buy: Here's Why - MSN
Millennium Management LLC Acquires New Holdings in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals (ETON) Is a Great Choice for 'Trend' Investors, Here's Why - sharewise
Equities Analysts Offer Predictions for ETON Q3 Earnings - Defense World
Eton Pharmaceuticals (ETON) Target Price Raised to $35 by HC Wai - GuruFocus
Eton Pharmaceuticals Inc (ETON) Shares Down 4.98% on May 29 - GuruFocus
FDA Approves Eton Pharma's Oral Drug For Adrenal Insufficiency In Pediatric Patients, Analyst Sees Boost In 2025 Revenue - Benzinga
Sector Update: Health Care - marketscreener.com
Eton Pharmaceuticals stock rises on FDA approval of KHINDIVI By Investing.com - Investing.com Nigeria
Northern Trust Corp Purchases 22,827 Shares of Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Eton Pharmaceuticals stock rises on FDA approval of KHINDIVI - Investing.com Australia
Eton Pharma stock gains on FDA nod for Khindivi (ETON:NASDAQ) - Seeking Alpha
Eton Pharmaceuticals (ETON) Price Target Raised After FDA Approval | ETON Stock News - GuruFocus
Eton Pharmaceuticals Gains FDA Approval for KHINDIVI - TipRanks
Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution - GlobeNewswire
Trading (ETON) With Integrated Risk Controls - news.stocktradersdaily.com
Jane Street Group LLC Has $857,000 Stake in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
individual investors who own 43% along with institutions invested in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) saw increase in their holdings value last week - Yahoo Finance
Eton Pharmaceuticals Set To Dominate Orphan Drug Niche (NASDAQ:ETON) - Seeking Alpha
Eton Pharmaceuticals Inc (ETON) Shares Up 3.33% on May 19 - GuruFocus
Balyasny Asset Management L.P. Invests $158,000 in Eton Pharmaceuticals, Inc. (NASDAQ:ETON) - Defense World
Q3 EPS Estimates for Eton Pharmaceuticals Cut by B. Riley - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Earns “Buy” Rating from B. Riley - Defense World
Eton Pharmaceuticals Inc (ETON) Shares Down 3.4% on May 16 - GuruFocus
(ETON) Trading Report - news.stocktradersdaily.com
Eton Pharmaceuticals (NASDAQ:ETON) Price Target Raised to $28.00 - Defense World
HC Wainwright Has Negative Outlook of ETON Q2 Earnings - Defense World
Eton Pharmaceuticals (ETON) Price Target Raised by B. Riley Secu - GuruFocus
Eton Pharmaceuticals (ETON) Price Target Raised by B. Riley Securities | ETON Stock News - GuruFocus
Finanzdaten der Eton Pharmaceuticals Inc-Aktie (ETON)
Umsatz
Nettogewinn
Free Cashflow
ENV
Eton Pharmaceuticals Inc-Aktie (ETON) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Krempa David | Chief Business Officer |
Jun 16 '25 |
Sale |
14.73 |
10,223 |
150,585 |
612,646 |
| Krempa David | Chief Business Officer |
Jun 13 '25 |
Sale |
14.77 |
6,800 |
100,436 |
622,869 |
| Opaleye Management Inc. | 10% Owner |
Jun 10 '25 |
Buy |
15.82 |
7,930 |
125,484 |
2,770,000 |
0.07%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):